Correlation Between Bone Biologics and Vivos

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Vivos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Vivos into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Vivos Inc, you can compare the effects of market volatilities on Bone Biologics and Vivos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Vivos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Vivos.

Diversification Opportunities for Bone Biologics and Vivos

0.82

Correlation Coefficient

Bone Biologics  Vivos

Very poor diversification

The 3 months correlation between Bone and Vivos is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Vivos Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Inc and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Vivos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Inc has no effect on the direction of Bone Biologics i.e., Bone Biologics and Vivos go up and down completely randomly.

Pair Corralation between Bone Biologics and Vivos

Assuming the 90 days horizon Bone Biologics Corp is expected to under-perform the Vivos. But the stock apears to be less risky and, when comparing its historical volatility, Bone Biologics Corp is 9.94 times less risky than Vivos. The stock trades about -0.22 of its potential returns per unit of risk. The Vivos Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  8.50  in Vivos Inc on September 23, 2024 and sell it today you would earn a total of  0.30  from holding Vivos Inc or generate 3.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.45%
Values	Daily Returns

Bone Biologics Corp  vs.  Vivos Inc

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Vivos Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vivos Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Bone Biologics and Vivos

The main advantage of trading using opposite Bone Biologics and Vivos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Vivos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos will offset losses from the drop in Vivos' long position.

The idea behind Bone Biologics Corp and Vivos Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.